It has been shown that BRAFV600E and PTEN loss facilitates the progression of thyroid cancers when the fibroblast-mediated collagen remodeling takes place within the tumor microenvironment suggesting a possibility of synergism in tumor progression [35]. This evidence concerns the gene PTEN and thyroid gland carcinoma.